335 related articles for article (PubMed ID: 28281738)
1. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of nicorandil and ranolazine in prevention of contrast-induced nephropathy in patients with mild-to-moderate renal dysfunction: a randomized controlled trial.
Yusuf J; Prakash G; Safal S; Mehta V; Mukhopadhyay S
Coron Artery Dis; 2024 May; 35(3):186-192. PubMed ID: 38411168
[TBL] [Abstract][Full Text] [Related]
3. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
Boccalandro F; Amhad M; Smalling RW; Sdringola S
Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
[TBL] [Abstract][Full Text] [Related]
4. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
[TBL] [Abstract][Full Text] [Related]
5. Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.
Vasheghani-Farahani A; Sadigh G; Kassaian SE; Khatami SM; Fotouhi A; Razavi SA; Mansournia MA; Yamini-Sharif A; Amirzadegan A; Salarifar M; Sadeghian S; Davoodi G; Borumand MA; Esfehani FA; Darabian S
Am J Kidney Dis; 2009 Oct; 54(4):610-8. PubMed ID: 19619921
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
[TBL] [Abstract][Full Text] [Related]
7. Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial.
Hölscher B; Heitmeyer C; Fobker M; Breithardt G; Schaefer RM; Reinecke H
Can J Cardiol; 2008 Nov; 24(11):845-50. PubMed ID: 18987758
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial.
Amini M; Salarifar M; Amirbaigloo A; Masoudkabir F; Esfahani F
Trials; 2009 Jun; 10():45. PubMed ID: 19563648
[TBL] [Abstract][Full Text] [Related]
9. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
Möckel M; Radovic M; Kühnle Y; Combé V; Waigand J; Schröder S; Dietz R; Frei U; Eckardt KU
Nephrol Dial Transplant; 2008 May; 23(5):1588-94. PubMed ID: 18175785
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial.
Reinecke H; Fobker M; Wellmann J; Becke B; Fleiter J; Heitmeyer C; Breithardt G; Hense HW; Schaefer RM
Clin Res Cardiol; 2007 Mar; 96(3):130-9. PubMed ID: 17180572
[TBL] [Abstract][Full Text] [Related]
11. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
Worasuwannarak S; Pornratanarangsi S
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
[TBL] [Abstract][Full Text] [Related]
12. Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial.
Jones DA; Beirne AM; Kelham M; Wynne L; Andiapen M; Rathod KS; Parakaw T; Adams J; Learoyd A; Khan K; Godec T; Wright P; Antoniou S; Wragg A; Yaqoob M; Mathur A; Ahluwalia A
Eur Heart J; 2024 May; 45(18):1647-1658. PubMed ID: 38513060
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure.
Tamura A; Goto Y; Miyamoto K; Naono S; Kawano Y; Kotoku M; Watanabe T; Kadota J
Am J Cardiol; 2009 Oct; 104(7):921-5. PubMed ID: 19766757
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
Toso A; Maioli M; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Manzone C; Amato M; Bellandi F
Am J Cardiol; 2010 Feb; 105(3):288-92. PubMed ID: 20102936
[TBL] [Abstract][Full Text] [Related]
15. Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial.
Fung JW; Szeto CC; Chan WW; Kum LC; Chan AK; Wong JT; Wu EB; Yip GW; Chan JY; Yu CM; Woo KS; Sanderson JE
Am J Kidney Dis; 2004 May; 43(5):801-8. PubMed ID: 15112170
[TBL] [Abstract][Full Text] [Related]
16. Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: a meta-analysis.
Misra D; Leibowitz K; Gowda RM; Shapiro M; Khan IA
Clin Cardiol; 2004 Nov; 27(11):607-10. PubMed ID: 15562929
[TBL] [Abstract][Full Text] [Related]
17. The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography.
Weisbord SD; Hartwig KC; Sonel AF; Fine MJ; Palevsky P
Catheter Cardiovasc Interv; 2008 Jun; 71(7):879-85. PubMed ID: 18412255
[TBL] [Abstract][Full Text] [Related]
18. NITRATE-CIN Study: Protocol of a Randomized (1:1) Single-Center, UK, Double-Blind Placebo-Controlled Trial Testing the Effect of Inorganic Nitrate on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography for Acute Coronary Syndromes.
Beirne AM; Mitchelmore O; Palma S; Andiapen M; Rathod KS; Hammond V; Bellin A; Cooper J; Wright P; Antoniou S; Yaqoob MM; Naci H; Mathur A; Ahluwalia A; Jones DA
J Cardiovasc Pharmacol Ther; 2021 Jul; 26(4):303-309. PubMed ID: 33764198
[TBL] [Abstract][Full Text] [Related]
19. Effect of Curcuminoids on Contrast-Induced Acute Kidney Injury after Elective Coronary Angiography or Intervention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study.
Noppakun K; Jitraknatee J; Suteeka Y; Ruengorn C; Nochaiwong S; Gunaparn S; Phrommintikul A; Wongcharoen W
Cardiorenal Med; 2024; 14(1):160-166. PubMed ID: 38350427
[TBL] [Abstract][Full Text] [Related]
20. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty.
Mueller C; Buerkle G; Buettner HJ; Petersen J; Perruchoud AP; Eriksson U; Marsch S; Roskamm H
Arch Intern Med; 2002 Feb; 162(3):329-36. PubMed ID: 11822926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]